Evaluation of serum-based inflammatory and haematological markers in patients with endometriosis: A case-control study

Dilara Sarikaya Kurt, Kurt DS, Dilara Kurt, Akay A, Arife Akay, Can Ozan Ulusoy, Ulusoy CO, Ahmet Kurt, Kurt A, Gülşan Karabay, Karabay G, Keskin HL, Hüseyin Levent Keskin
European journal of obstetrics, gynecology, and reproductive biology · 2025 · vol. 315 , pp. 114751 · doi:10.1016/j.ejogrb.2025.114751 · PMID:41045781 · W4414796845
Other OA: closed CC0
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This case-control study evaluated serum inflammatory and hematological markers in patients with endometriosis to identify potential diagnostic or prognostic indicators.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: To assess the diagnostic value of serum-based inflammatory and haematological markers in women with endometriosis, and determine their relationship with disease severity, including lesion characteristics. MATERIALS AND METHODS: This prospective study included 103 patients with endometriosis (aged 18-45 years) and 103 healthy controls. Serum C-reactive protein (CRP), albumin and complete blood counts were obtained pre-operatively, and inflammatory markers [neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio, neutrophil-to-platelet ratio (NPAR), CRP-to-albumin ratio (CAR), systemic inflammation index (SII), systemic inflammatory response index (SIRI) and pro-inflammatory index (PIV)] were calculated. Surgical evaluation (laparoscopy/laparotomy) provided histopathological confirmation of endometriosis. The 1996 revised American Society for Reproductive Medicine (rASRM) classification was used for staging. Statistical analyses used t-tests, Mann-Whitney U-tests, Chi-squared tests, Spearman's correlation, and linear regression modelling. p < 0.05 was considered to indicate significance. RESULTS: Compared with controls, patients with endometriosis had lower white blood cell (7.28 vs 8.43 × 103/mm3; p < 0.001), neutrophil (4.17 vs 5.09 × 103/mm3; p < 0.001) and CRP (2.45 vs 3.34 mg/l; p = 0.008) levels, but higher haemoglobin (12.8 vs 11.9 g/dl; p = 0.001) and haematocrit (40.5 % vs 38.1 %; p < 0.001) levels. NPAR (1.38 vs 1.48; p < 0.001), SII (539 vs 737; p < 0.001), SIRI (1004 vs 1337; p < 0.001), PIV (302 vs 422; p < 0.001), CAR (0.061 vs 0.079; p = 0.008) and NLR (1.89 vs 2.44; p < 0.001) were also significantly lower in patients with endometriosis. Postoperatively, NLR, SIRI, PIV and NPAR increased (p < 0.05). Receiver operating characteristic curve analysis indicated moderate diagnostic performance for neutrophil percentage, NLR, SII, SIRI and PIV. On multi-variate analysis, bilaterality (p < 0.001) and area of endometriomas (p = 0.020) correlated with rASRM score. CONCLUSION: Serum inflammatory markers reflect systemic immune changes in endometriosis. Although they offer diagnostic insights, lesion bilaterality and size remain stronger predictors of disease severity. Larger, multi-centre studies are needed to refine cut-off values and optimize clinical application of these markers.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

C-Reactive Protein C-Reactive Protein C-Reactive Protein C-Reactive Protein C-Reactive Protein C-Reactive Protein C-Reactive Protein C-Reactive Protein C-Reactive Protein C-Reactive Protein C-Reactive Protein C-Reactive Protein C-Reactive Protein C-Reactive Protein C-Reactive Protein C-Reactive Protein C-Reactive Protein C-Reactive Protein C-Reactive Protein C-Reactive Protein

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (30)

Source provenance

europepmc
last seen: 2026-10-19T06:17:24.038039+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-19T06:12:55.363545+00:00
unpaywall
last seen: 2026-10-19T06:34:38.229974+00:00
License: CC0 · commercial use OK